Clinical development
- First Subject Dosed in Initial Cohort of Phase 2b Clinical Study of CyanVac’s Intranasal COVID-19 Vaccine Candidate
09 Dec, 2024 - Zydus Lifscience gets CDSCO Panel nod to study Rabies Vaccine
08 Dec, 2024 - Nepal’s success in typhoid vaccine trial
07 Dec, 2024 - Vaccine Clinical Trials Global Landscape Whitepaper (2024)
05 Dec, 2024 - Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants
04 Dec, 2024 - GSK axes hepatitis B vaccine trial after missing efficacy goal
04 Dec, 2024 - Could there be a Breast cancer vaccine on the horizon? Here’s what we know
04 Dec, 2024 - Nasal COVID-19 vaccine trials seek healthy volunteers in Greater Cincinnati
03 Dec, 2024 - Moderna down 3% as Leerink expresses concern over CMV vaccine candidate
03 Dec, 2024 - Valneva’s Chikungunya Shot Shows Strong, Long-Lasting Antibody Persistence At Three Years, Comparable In Older And Younger Adults
03 Dec, 2024 - The United States has completed the study of a unique HIV vaccine
03 Dec, 2024 - Elicio completes phase 2 enrollment for cancer vaccine
03 Dec, 2024 - Genetic Immunity (GI) Leverages VectorBuilder Partnership to Power Phase 3 HIV Vaccine Trials
03 Dec, 2024 - ACTG Announces Publication of BEe-HIVe Trial in JAMA
03 Dec, 2024 - BCG Vaccine May Protect Against Long COVID Symptoms
03 Dec, 2024 - Cancer Center study if vaccines can prevent lung cancer recurrence
03 Dec, 2024 - Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
02 Dec, 2024
0 Comments